Zhang, Shenpeng R <br/><br/>
IL-33 modulates inflammatory brain injury but exacerbates systemic immunosuppression following ischemic stroke.  [electronic resource] 

 -  JCI insight  09 2018 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2379-3708 
<br/><br/><label>Standard No.: </label>10.1172/jci.insight.121560  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Brain Injuries--metabolism<br/>Brain Ischemia--metabolism<br/>Cytokines--blood<br/>Disease Models, Animal<br/>Inflammation<br/>Interleukin-10--metabolism<br/>Interleukin-33--metabolism<br/>Interleukin-4--pharmacology<br/>Lung--drug effects<br/>Macrophages--drug effects<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Microglia--drug effects<br/>Stroke--metabolism<br/>Th1 Cells--metabolism<br/>Th2 Cells--metabolism<br/>Treatment Outcome<br/>Tyrosine--analogs & derivatives